Genomic Valley Biotech (539206.BO) Stock Price
Genomic Valley Biotech Price
Revenue has compounded at 128.7% per year over the past 3 years to 8.44 M INR. Earnings per share have declined at 25.9% per year over the last 2 years. Genomic Valley Biotech's net margin stands at 42.2%, up from -13.2% several years earlier.
Genomic Valley Biotech stock price
Genomic Valley Biotech business model & stock analysis
Frequently asked questions about Genomic Valley Biotech
Converted at the current exchange rate, the Genomic Valley Biotech share trades at 0.28 EUR (29.95 INR).
The revenue cannot currently be calculated for Genomic Valley Biotech.
The profit cannot currently be calculated for Genomic Valley Biotech.
The P/E ratio cannot be calculated for Genomic Valley Biotech at the moment.
The P/S cannot be calculated for Genomic Valley Biotech currently.
The Eulerpool Quality Score for Genomic Valley Biotech is 3/10.
The ISIN of Genomic Valley Biotech is INE574D01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Genomic Valley Biotech is 539206.BO. The ticker symbol is used to trade Genomic Valley Biotech shares on the stock exchange.
Genomic Valley Biotech stock
Genomic Valley Biotech Peer Group
Genomic Valley Biotech Ticker
Genomic Valley Biotech FIGI
All fundamentals and in-depth analysis of Genomic Valley Biotech
Our stock analysis for Genomic Valley Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genomic Valley Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.